Giuseppe Derosa

13.8k total citations · 1 hit paper
337 papers, 10.5k citations indexed

About

Giuseppe Derosa is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Giuseppe Derosa has authored 337 papers receiving a total of 10.5k indexed citations (citations by other indexed papers that have themselves been cited), including 178 papers in Endocrinology, Diabetes and Metabolism, 96 papers in Cardiology and Cardiovascular Medicine and 89 papers in Molecular Biology. Recurrent topics in Giuseppe Derosa's work include Diabetes Treatment and Management (82 papers), Metabolism, Diabetes, and Cancer (62 papers) and Blood Pressure and Hypertension Studies (56 papers). Giuseppe Derosa is often cited by papers focused on Diabetes Treatment and Management (82 papers), Metabolism, Diabetes, and Cancer (62 papers) and Blood Pressure and Hypertension Studies (56 papers). Giuseppe Derosa collaborates with scholars based in Italy, Iran and United States. Giuseppe Derosa's co-authors include Pamela Maffioli, Arrigo F.G. Cicero, Angela D’Angelo, Amirhossein Sahebkar, Roberto Fogari, Elena Fogari, Leonardina Ciccarelli, Amedeo Mugellini, Sibilla Salvadeo and Ilaria Ferrari and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Giuseppe Derosa

333 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

State of the art paper Sulfonylureas and their use in clinical practice

2015 376 citations Pamela Maffioli, Giuseppe Derosa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giuseppe Derosa Italy	54	4.2k	3.1k	1.8k	1.8k	1.7k	337	10.5k
Jerry L. Nadler United States	68	3.5k 0.8×	4.6k 1.5×	1.6k 0.8×	2.6k 1.5×	1.6k 1.0×	256	13.8k
Arrigo F.G. Cicero Italy	68	4.0k 0.9×	4.4k 1.4×	2.3k 1.2×	3.2k 1.8×	2.1k 1.2×	581	16.9k
Tony Hayek Israel	47	2.3k 0.5×	2.4k 0.8×	1.5k 0.8×	2.8k 1.5×	636 0.4×	111	9.8k
Jorge Joven Spain	62	1.5k 0.4×	3.9k 1.3×	955 0.5×	1.9k 1.0×	971 0.6×	377	12.2k
Matteo Pirro Italy	62	1.6k 0.4×	2.7k 0.9×	2.3k 1.3×	2.7k 1.5×	653 0.4×	263	11.2k
Paul Fu United States	24	2.5k 0.6×	2.1k 0.7×	868 0.5×	1.8k 1.0×	463 0.3×	59	9.6k
Husam Ghanim United States	53	4.0k 1.0×	2.5k 0.8×	1.7k 0.9×	1.3k 0.7×	996 0.6×	116	10.9k
Dimitri P. Mikhailidis United Kingdom	59	3.4k 0.8×	1.8k 0.6×	3.4k 1.9×	6.2k 3.5×	1.1k 0.6×	421	14.8k
Niki Katsiki Greece	48	2.6k 0.6×	1.7k 0.5×	1.6k 0.9×	2.0k 1.1×	514 0.3×	299	8.6k
Anatol Kontush France	55	4.6k 1.1×	3.0k 1.0×	1.8k 1.0×	4.2k 2.4×	570 0.3×	163	11.7k

Countries citing papers authored by Giuseppe Derosa

Since Specialization

Citations

This map shows the geographic impact of Giuseppe Derosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe Derosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe Derosa more than expected).

Fields of papers citing papers by Giuseppe Derosa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe Derosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe Derosa. The network helps show where Giuseppe Derosa may publish in the future.

Co-authorship network of co-authors of Giuseppe Derosa

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe Derosa. A scholar is included among the top collaborators of Giuseppe Derosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe Derosa. Giuseppe Derosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Derosa, Giuseppe, Angela D’Angelo, Pamela Maffioli, Laura Cucinella, & Rossella E. Nappi. (2024). The Use of Nigella sativa in Cardiometabolic Diseases. Biomedicines. 12(2). 405–405. 5 indexed citations

Derosa, Giuseppe, Angela D’Angelo, Francesco Angelini, et al.. (2024). Nutraceuticals and Supplements in Management of Prediabetes and Diabetes. Nutrients. 17(1). 14–14. 6 indexed citations

Pierro, Francesco Di, Giuseppe Derosa, Pamela Maffioli, et al.. (2021). Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study. International Journal of General Medicine. Volume 14. 2359–2366. 132 indexed citations

Pierro, Francesco Di, Somia Iqtadar, Amjad Khan, et al.. (2021). Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial. International Journal of General Medicine. Volume 14. 2807–2816. 132 indexed citations

Derosa, Giuseppe, Angela D’Angelo, Paola Preti, & Pamela Maffioli. (2020). Safety and Efficacy of Alpha Lipoic Acid During 4 Years of Observation: A Retrospective, Clinical Trial in Healthy Subjects in Primary Prevention. SHILAP Revista de lepidopterología. 1 indexed citations

Derosa, Giuseppe, et al.. (2020). An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia. SHILAP Revista de lepidopterología. 1 indexed citations

Derosa, Giuseppe, et al.. (2020). <p>An Evaluation of a Nutraceutical with Berberine, Curcumin, Inositol, Banaba and Chromium Picolinate in Patients with Fasting Dysglycemia</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 653–661. 18 indexed citations

Pierro, Francesco Di, Aadil Khan, Alexander Bertuccioli, et al.. (2020). Quercetin Phytosome R as a potential candidate for managing COVID-19. 10. 5–5. 10 indexed citations

Scelsi, Laura, Stefano Ghio, Benedetta Matrone, et al.. (2020). Galectin-3 Plasma Levels Are Associated with Risk Profiles in Pulmonary Arterial Hypertension. Diagnostics. 10(11). 857–857. 10 indexed citations

10.

Derosa, Giuseppe, Pamela Maffioli, Laura Scelsi, et al.. (2018). Canrenone on cardiovascular mortality in congestive heart failure. Pharmacological Research. 141. 46–52. 6 indexed citations

11.

Derosa, Giuseppe, Angela D’Angelo, Davide Romano, & Pamela Maffioli. (2017). Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetes. Drug Design Development and Therapy. Volume 11. 1481–1488. 37 indexed citations

12.

Cicero, Arrigo F.G., Giuseppe Derosa, Pamela Maffioli, et al.. (2013). Berberine induced improvement in hepatic steatosis index in overweight dyslipidaemic patients treated with lipid-lowering nutraceuticals. Current Topics in Nutraceutical Research. 11. 41–45. 3 indexed citations

13.

Derosa, Giuseppe, Fabrizio Querci, Anna Carbone, et al.. (2012). Exenatide plus metformin compared with metformin alone on β‐cell function in patients with Type 2 diabetes. Diabetic Medicine. 29(12). 1515–1523. 58 indexed citations

14.

Derosa, Giuseppe & Pamela Maffioli. (2012). Dipeptidyl Peptidase-4 Inhibitors: 3 Years of Experience. Diabetes Technology & Therapeutics. 14(4). 350–364. 47 indexed citations

15.

Derosa, Giuseppe & Sibilla Salvadeo. (2010). Endothelial function, blood pressure control, and risk modification: impact of irbesartan alone or in combination. SHILAP Revista de lepidopterología. 1 indexed citations

16.

Derosa, Giuseppe, et al.. (2007). Optimizing combination treatment in the management of type 2 diabetes. SHILAP Revista de lepidopterología. 25 indexed citations

17.

Derosa, Giuseppe, A. Gaddi, Mario N. Piccinni, et al.. (2005). Antithrombotic Effects of Rosiglitazone‐Metformin versus Glimepiride‐Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(5). 637–645. 21 indexed citations

18.

Derosa, Giuseppe, Maria Antonietta Avanzini, Diego Geroldi, et al.. (2005). Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus. Diabetes Research and Clinical Practice. 70(2). 119–125. 34 indexed citations

19.

Cicero, Arrigo F.G., Giuseppe Derosa, & A. Gaddi. (2004). What do herbalists suggest to diabetic patients in order to improve glycemic control? Evaluation of scientific evidence and potential risks. Acta Diabetologica. 41(3). 91–98. 51 indexed citations

20.

Derosa, Giuseppe, Arrigo F.G. Cicero, A. Gaddi, et al.. (2004). A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. Diabetes Research and Clinical Practice. 69(1). 5–13. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact